Cleveland Biolabs Inc (NASDAQ:CBLI)

3.37
Delayed Data
As of Feb 16
 -0.077 / -2.23%
Today’s Change
1.35
Today|||52-Week Range
5.55
-15.88%
Year-to-Date
No recent news for Cleveland Biolabs Inc.

Today’s Trading

Previous close3.45
Today’s open3.45
Day’s range3.31 - 3.45
Volume4,390
Average volume (3 months)28,404
Market cap$38.0M
Data as of 1:36pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)+86.59%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+29.92%
P/E ratioNM
Price/Sales4.43
Price/Book4.93

Competitors

 Today’s
change
Today’s
% change
CATBCatabasis Pharmaceut...+0.21+15.11%
SLNOSoleno Therapeutics ...-0.11-6.36%
TTNPTitan Pharmaceutical...0.000.00%
IPCIIntellipharmaceutics...-0.07-9.32%
Data as of 4:00pm ET, 02/16/2018

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$3.5M
Annual profit (last year)-$2.7M
Net profit margin-75.57%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Yakov Kogan
President &
Chief Medical Officer
Langdon L. Miller
Corporate headquarters
Buffalo, New York

Forecasts